Abstract 2273: Targeting the PI3K/AKT/mTOR pathway for the treatment of metaplastic breast cancer: Does location of PIK3CA mutation or histology affect responseReva K. Basho,Michael Gilcrease,Rashmi K. Murthy,Thorunn Helgason,Daniel J. Booser,Daniel D. Karp,Funda Meric-Bernstam,Kenneth R. Hess,Shelley M. Herbrich,Vicente Valero,Constance Albarracin,Jennifer Litton,Mariana Chavez-MacGregor,Nuhad K. Ibrahim,James L. Murray,Kimberly B. Koenig,David Hong,Vivek Subbiah,Razelle Kurzrock,Filip Janku,Stacy MoulderClinical Research (Excluding Clinical Trials)（2016）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
